Galant C - Search Results

1

Genomic grade adds prognostic value in invasive lobular carcinoma.

Metzger-Filho O, Michiels S, Bertucci F, Catteau A, Salgado R, Galant C, Fumagalli D, Singhal SK, Desmedt C, Ignatiadis M, Haussy S, Finetti P, Birnbaum D, Saini KS, Berlière M, Veys I, de Azambuja E, Bozovic I, Peyro-Saint-Paul H, Larsimont D, Piccart M, Sotiriou C. Metzger-Filho O, et al. Among authors: galant c. Ann Oncol. 2013 Feb;24(2):377-384. doi: 10.1093/annonc/mds280. Epub 2012 Oct 1. Ann Oncol. 2013. PMID: 23028037 Free article.

2

Two schwannomas presenting as lumps in the same breast.

Galant C, Mazy S, Berliere M, Mazy G, Wallon J, Marbaix E. Galant C, et al. Diagn Cytopathol. 1997 Mar;16(3):281-4. doi: 10.1002/(sici)1097-0339(199703)16:3<281::aid-dc18>3.0.co;2-h. Diagn Cytopathol. 1997. PMID: 9099554

3

Uterine side effects of tamoxifen: a need for systematic pretreatment screening.

Berlière M, Charles A, Galant C, Donnez J. Berlière M, et al. Among authors: galant c. Obstet Gynecol. 1998 Jan;91(1):40-4. doi: 10.1016/s0029-7844(97)00591-7. Obstet Gynecol. 1998. PMID: 9464718

4

[Endometrial evaluation prior to tamoxifen: preliminary results of a prospective study].

Berlière M, Galant C, Gillerot S, Charles A, Donnez J. Berlière M, et al. Among authors: galant c. Bull Cancer. 1998 Aug;85(8):721-4. Bull Cancer. 1998. PMID: 9754081 Free article. French.

5

The potential oncogenic effect of tamoxifen on the endometrium.

Berlière M, Galant C, Donnez J. Berlière M, et al. Among authors: galant c. Hum Reprod. 1999 May;14(5):1381-3. doi: 10.1093/humrep/14.5.1381. Hum Reprod. 1999. PMID: 10325299

6

Identification of women at high risk of developing endometrial cancer on tamoxifen.

Berlière M, Radikov G, Galant C, Piette P, Marbaix E, Donnez J. Berlière M, et al. Among authors: galant c. Eur J Cancer. 2000 Sep;36 Suppl 4:S35-6. doi: 10.1016/s0959-8049(00)00217-3. Eur J Cancer. 2000. PMID: 11056310 No abstract available.

7

Immunolocalisation of cytochrome P-450 3A enzymes in human breast carcinoma: relationship with tumour differentiation and steroid receptors.

Galant C, Gala JL, Van Den Berge V, Berlière M, Haumont E, Horsmans Y. Galant C, et al. Pharmacol Toxicol. 2001 Mar;88(3):142-6. doi: 10.1034/j.1600-0773.2001.d01-95.x. Pharmacol Toxicol. 2001. PMID: 11245409

8

[Localization of non-palpable breast lesions with black carbon powder (experience of the Catholic University of Louvain)].

Mazy S, Galant C, Berlière M, Mazy G. Mazy S, et al. Among authors: galant c. J Radiol. 2001 Feb;82(2):161-4. J Radiol. 2001. PMID: 11428211 French.

9

Endometrial evaluation is a very important tool in the management of breast cancer patients.

Berlière M, Galant C, Charles A, Brichard V, Piette P, Donnez J. Berlière M, et al. Among authors: galant c. Eur J Cancer. 2002 Nov;38 Suppl 6:S67-8. doi: 10.1016/s0959-8049(02)00292-7. Eur J Cancer. 2002. PMID: 12409081 No abstract available.

10

A new, liquid-based cytology technique.

Weynand B, Berlière M, Haumont E, Massart F, Pourvoyeur A, Bernard P, Donnez J, Galant C. Weynand B, et al. Among authors: galant c. Acta Cytol. 2003 Mar-Apr;47(2):149-53. doi: 10.1159/000326495. Acta Cytol. 2003. PMID: 12685180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters